Pfizer stops funding for-profit CME classes; FDA panel votes to require cardiovascular safety proof for diabetes drugs;

> Pharmaceutical giant Pfizer has decided to stop funding CME classes taught by for-profit third-party companies. FiercePharma

> An FDA panel has voted to recommended that developers of diabetes drugs specifically prove that their experimental therapies don't increase cardiovascular risks, a decision that could cost pharmaceutical companies big bucks. FierceBiotech

> A federal advisory panel has recommended that children get combination vaccines, including a four-in-one shot protecting against diphtheria, tetanus, pertussis and polio. FierceVaccines

> The DEA has finally released e-prescribing regulations for controlled drugs, a move that may stand to make e-prescribing far more popular with doctors. FierceHealthIT

And Finally... When the Declaration of Independence was signed, five doctors added their John Hancock to the list. Blog

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.